Andrew Brack @ 2024 Biomarkers of Aging Conference

Dr. Brack explains how ARPA-H, a U.S. research funding agency that supports transformative biomedical and health breakthroughs - ranging from the molecular to the societal - aims to deliver health solutions for all. He highlights programs such as the Biomarkers of Aging Consortium as key examples of this mission.
Timestamps:
[00:02:29] Intro ARPA-H and mission focus areas
[00:05:58] Program and program manager flywheel
[00:07:54] ARPA-H model: Program formation
[00:09:30] ARPA-H model: Program lifecycle
[00:11:07] How ARPA-H accelerates the entire health ecosystem
[00:11:42] ARPA-H model: Execution and evaluation
[00:12:50] Supporting healthspan therapeutics innovation
Dr. Andrew Brack joined the Advanced Research Projects Agency for Health (ARPA-H) from the Department of Orthopaedic Surgery at the University of California, San Francisco. For 16 years, his lab studied the cellular and molecular mechanisms regulating skeletal muscle repair during aging. He also co-founded Arrive Bio, a longevity company leveraging machine learning to identify drugs for treating age-related diseases. Throughout his career, Dr. Brack has led multidisciplinary teams focused on restoring healthy function during aging.
Learn more about ARPA-H here: arpa-h.gov/